43
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T6729 |
Lomibuvir
VX-222,VCH-222 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Lomibuvir (VCH-222) (VX-222) 是丙型肝炎病毒 NS5B 聚合酶的一种非核苷变构抑制剂,Kd 值为 17 nM,已证明具有临床疗效。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 | |||
T4686 |
Simeprevir
TMC435,西咪匹韦,TMC-435350,Olysio |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Simeprevir (TMC435) 是一种有效的 HCV NS3/4A 蛋白酶抑制剂,抑制 HCV 复制,EC50 为 7.8 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T27586 |
IDX184
IDX-184,IDX 184 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
IDX184 是一种有效的,具有口服活性的靶向 HCV 聚合酶抑制剂和核苷聚合酶抑制剂。IDX184 有效抑制 HCV 聚合酶 (IC50=0.31 μM,Ki=52.3 nM)。 IDX184是一种肝脏靶向核苷酸前药,具有抗HCV活性,可抑制HCV NS5B聚合酶,可与聚乙二醇化干扰素-α2a 和利巴韦林联合用于初治慢性丙型肝炎。 | |||
T26815 |
BILB-1941
BILB 1941ZW,BILB1941ZW,BILB-1941ZW |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
BILB-1941 (BILB-1941ZW) 是 HCV NS5B 聚合酶的抑制剂,可用于 HCV 感染的研究。 | |||
T10493 |
Beclabuvir
BMS-791325 |
Others | Others |
Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the HCV NS5B RNA-dependent RNA polymerase. It inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 (IC50 < 28 nM). | |||
TQ0122L |
VCH-916 free acid(1200133-34-1 free base)
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
VCH-916 free acid(1200133-34-1 free base) 是一种新型非核苷 HCV NS5B 聚合酶抑制剂。 | |||
TQ0090 |
Nesbuvir
HCV-796 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Nesbuvir 是一种选择性丙型肝炎病毒(HCV)非结构蛋白5B(NS5B)RNA 依赖性聚合酶抑制剂。Nesbuvir 对含1b HCV 复制子的肝癌细胞的 IC50为9nM。 | |||
T17029 |
Tegobuvir
GS-9190,GS 333126,5-[[6-[2,4-双(三氟甲基)苯基]-3-哒嗪基]甲基]-2-(2-氟苯基)-5H-咪唑并[4,5-C]吡啶 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Tegobuvir (GS 333126) 是特异性共价的HCV NS5B 聚合酶抑制剂。 | |||
T2117 |
PSI-6206
2'-deoxy-2'-fluoro-2'-C-methyluridine,RO 2433,GS-331007 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
PSI-6206 (RO 2433) 是 PSI-6130 的脱氨衍生物,PSI-6206 是一种选择性 HCV RNA 聚合酶抑制剂,低效抑制HCV 复制,EC90为 >100 μM。PSI-6130 是一种有效的选择性 HCV NS5B 聚合酶抑制剂。 | |||
T16710 |
Mericitabine
R-7128,RG 7128,PSI 6130 diisobutyrate |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Mericitabine (R-7128) 是一种核苷HCV NS5B 聚合酶抑制剂。它充当 RNA 链终止子并防止 RNA 转录物在复制过程中延伸。 | |||
T15282 |
Filibuvir
PF-00868554 |
HCV Protease; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
Filibuvir (PF-00868554) 是 HCV NS5B RNA 依赖性 RNA 聚合酶的选择性非共价抑制剂。 Filibuvir 抑制基因型 1a 和 1b 复制子,EC50 为 59 nM。 | |||
TNU0442 |
2’-beta-C-Methyl inosine
2'-C-Methylinosine |
Antiviral; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Immunology/Inflammation |
2’-beta-C-Methyl inosine (2'-C-Methylinosine) 是一种 HCV RNA聚合酶抑制剂,具有抗病毒活性,可用用于研究用于治疗丙型肝炎病毒感染。 | |||
T6676 |
Sofosbuvir
索非布韦,GS 7977,PSI-7977 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir (GS 7977) 是一种丙型肝炎病毒聚合酶 NS5B 的尿苷单磷酸类似物抑制剂,用作治疗慢性丙型肝炎的抗病毒剂。 | |||
T21537L |
TMC647055 Choline Hydroxide Salt
TMC647055 Choline Hydroxide Salt (1204416-97-6 free base) |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
TMC647055 Choline Hydroxide Salt 是一种新型有效的 HCV NS5B 聚合酶非核苷抑制剂,可用于治疗 HCV 感染。它具有纳摩尔级细胞效力(EC(50) 为 82 nM),相关细胞毒性较小(CC(50)>20 μM),在大鼠和狗中具有良好的药代动力学特征。 TMC647055 显示出有体外生化、动力学和病毒学特征的前景。 | |||
T28762 |
Setrobuvir
RO-5466731,ANA-598,RG7790,ANA598,RG-7790 |
HCV Protease; SARS-CoV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
Setrobuvir (ANA-598) 是一种口服活性非核苷类HCV NS5B 聚合酶抑制剂,对新的RNA 合成和引物延伸具有抑制作用,IC50s 在4到5nM 之间。Setrobuvir 对SARS-CoV-2 RdRp 显示出很好的结合亲和力,能诱导RdRp 受到抑制。 | |||
T7215 |
NM107
NM-107,2'-C-甲基胞嘧啶核苷,2'-C-Methylcytidine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NM107 (2'-C-Methylcytidine) 是一种具有广谱抗病毒活性的核糖核苷,是丙型肝炎病毒 NS5B 聚合酶的核苷抑制剂,在野生型复制子细胞中的 EC50 为 1.85 μM。 | |||
T27587 |
IDX-375
|
||
IDX-375, a HCV NS5B polymerase inhibitor, is used potentially for the treatment of HCV infection. | |||
T29069 |
Uprifosbuvir
MK3682,IDX21437,IDX 21437,MK 3682,IDX-21437,MK-3682 |
||
Uprifosbuvir is an inhibitor of uridine nucleotide analog HCV NS5B polymerase. | |||
T27485 |
GSK-625433
|
||
GSK-625433, a homochiral inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, has the ability to inhibit the polymerase of both HCV genotypes 1a and 1b. | |||
T27530 |
HCV-086
HCV086 |
||
HCV-086, a RNA-directed RNA polymerase (NS5B) inhibitor, is used for the treatment of HCV infection. | |||
T32050 |
HCV-371
HCV 371 |
||
HCV-371 is a potent selective HCV NS5B polymerase inhibitor that shows broad inhibitory activity against NS5B RDRP and no inhibitory activity against a set of human polymerases (including mitochondrial DNA polymerase γ and other unrelated viral polymerase | |||
T28984 |
TMC-649128
TMC 649128 |
||
TMC-649128, a RNA polymerase NS5B inhibitor, is used for the treatment of HCV infection. | |||
TQ0122 |
VCH-916
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
VCH-916 是一种新型非核苷类 HCV NS5B 聚合酶抑制剂。 | |||
T26871 |
BMT-052
BMT052 |
||
BMT-052 is a potent and selective Pan-genotypic HCV NS5B Polymerase Inhibitor (EC50 = 7 nM). | |||
T39082 |
AL-611
|
||
AL-611 is an HCV NS5B polymerase inhibitor ( EC 50 = 5 nM). | |||
T12571 |
PSI-6206 13C,d3
Sofosbuvir metabolite GS-331007 13CD3,RO-2433 13CD3,PSI-6206 13CD3,GS-331007 13CD3 |
Others | Others |
PSI-6206 13CD3 is the deuterium labeled PSI-6206. PSI-6206 is a potent and selective HCV NS5B polymerase inhibitor. | |||
T15631 | JTK-853 | Others | Others |
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase. It also displays effective antiviral activity in HCV replicon cells (EC50s: 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively). | |||
T63593 |
Dasabuvir sodium
|
||
Dasabuvir (ABT-333) sodium 是非核苷丙型肝炎病毒 (HCV) 聚合酶抑制剂。Dasabuvir sodium 对 HCV NS5B 基因编码的 RNA 依赖性 RNA 聚合酶 (RNA polymerase) 表现出抑制作用。Dasabuvir sodium 能够抑制基因型 1a (菌株 H77) 复制子 (EC50: 7.7 nM) 和 1b (菌株 Con1) 复制子 (EC50: 1.8 nM)。 | |||
T38510 | ABT-072 potassium trihydrate | ||
ABT-072, also known as potassium trihydrate, is a highly effective non-nucleoside inhibitor of the HCV NS5B polymerase, administered orally. This compound exhibits potent activity against HCV GT1a (with an EC50 of 1 nM) and HCV GT1b (with an EC50 of 0.3 nM). | |||
T11352 |
Galidesivir triphosphate
BCX4430-triphosphate,Immucillin-A triphosphate,BCX6870 |
Others | Others |
Galidesivir triphosphate is a substrate for viral RNA-dependent RNA polymerase (RDRP), resulting in termination of viral RNA replication and thus serves as an antiviral. Galidesivir triphosphate inhibits HCV NS5B RNA polymerase activity and protects mice against Ebola. Galidesivir triphosphate (Immucillin-A triphosphate) is converted by the prodrug Galidesivir. | |||
T33432 |
MK-3281
MK 3281,MK3281 |
||
MK-3281 is a potent, orally bioavailable hepatitis C virus NS5B polymerase finger-loop inhibitor. It is also an inhibitor of attractive molecular properties with good potency in HCV subgenomic replication trials and suitable for clinical candidates. | |||
T63936 | GSK5852 | ||
GSK5852 (GSK2485852) 是 HCV NS5B RdRp 聚合酶抑制剂。GSK5852 能够抑制NS5B (IC50: 50 nM)。GSK5852 表现出抗病毒效果,能够丙型肝炎病毒 (HCV),对 GT1a 和 GT1b 的 EC50 值分别为 3.0 nM 和 1.7 nM。 | |||
T74070 | NHC-triphosphate tetrasodium | ||
NHC-triphosphate tetrasodium 是 NHC 的活性胞内磷酸盐代谢物 (intracellular metabolite),以三磷酸盐的形式存在。NHC-triphosphate tetrasodium 是病毒聚合酶 (viral polymerase) 的弱底物替代物,会被并入HCV 复制子 RNA 中。 | |||
T67814 |
TMC-649128 PM
|
||
TMC-649128 PM 是HCV NS5B RNA 依赖性RNA 聚合酶的有效核苷抑制剂,EC(50)值为1.2 muM,大鼠体内生物利用度中等(F=14%)。 | |||
T68235 |
Beclabuvir HCl
|
||
Beclabuvir, also known as BMS-791325, is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase. BMS-791325 inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 at 50% inhibitory concentrations (IC50) below 28 nM. In cell culture, BMS-791325 inhibited replication of HCV subgenomic replicons representing genotypes 1a and 1b at 50% effective concentrations (EC50s) of 3 nM and 6 nM, respectively, with similar (3 to 18 nM) ... | |||
T74301 |
PSI-353661
|
||
PSI-353661 (GS-558093) 是一种嘌呤核苷酸类NS5B 聚合酶抑制剂,可抵抗HCV 感染。PSI-353661抑制野生型和 S282T 抵抗性复制子HCV 的EC90s 分别为 8 nM 和 11 nM。PSI-353661 可在人原代肝细胞中产生高浓度的活性三磷酸。 | |||
T14493 |
Balapiravir
R1626,Ro 4588161 |
Others | Others |
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m | |||
T35533 |
6-Hydroxypyridin-3-ylboronic Acid
|
||
6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).16-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2 1.Hendricks, R.T., Spencer, S.R., Blake, J.F., et al.3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymeraseBioorg. Med. Chem. Lett.1... | |||
T73814 |
cis-Lomibuvir
|
||
cis-Lomibuvir (cis-VX-222) 是 Lomibuvir 的顺式异构体。Lomibuvir (VX-222) 是一种选择性的非核苷聚合酶抑制剂,靶向丙型肝炎病毒 NS5B 聚合酶 (RdRp) 的拇指口袋 2,Kd 为 17 nM。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 | |||
T36881 | NHC-diphosphate triammonium | ||
NHC-triphosphate triammonium is an active phosphorylated intracellular metabolite of β-d-N4-Hydroxycytidine (NHC) as a triphosphate form[1]. NHC-triphosphate triammonium is a weak alternative substrate for the viral polymerase and can be incorporated into HCV replicon RNA[1][2]. In an intracellular metabolism assay, HCV replicon cells are treated with 10 μM 3H-labeled NHC, and intracellular nucleotide levels are determined after 1, 2 and 8 hours incubations. NHC is rapidly convered into the mono... | |||
T70846 |
Deleobuvir sodium
|
||
Deleobuvir sodium is the salt form of Deleobuvir, also known as BI207127, a non-nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C. Deleobuvir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon-free regimens with other direct-acting antiviral agents including faldaprevir. Deleobuvir showed that a triple combination of deleobuvir, faldaprevir, and ribavirin performed well in HCV genotype 1b patients. Efficacy fell b... | |||
T38297 |
Ribavirin-13C5
Ribavirin-13C5 |
||
Ribavirin-13C5is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin is an antiviral guanosine nucleoside analog.1,2Upon entry into cells, ribavirin is metabolized to an active triphosphate form that induces viral RNA chain termination and inhibits viral polymerases. It reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 μg/ml).3Ribavirin also reduces replication of severe acute respiratory syndrome coro... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7607 |
PSI-6130
R 1656,2'-去氧-2'-氟-2'-C-甲基胞苷 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
PSI-6130 (R 1656) 是高效选择性 HCV NS5B 聚合酶抑制剂,抑制 HCV 复制,IC50值为 0.6 μM。 |